Closing Panel, • 9/22/25 Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Previous Case Studies in Rare Disease Commercialization: Lessons Learned You Might Also Like Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories What Matters to Payers: Conversations You Should Start During Phase 2 AI-Driven Patient Identification and Recruitment How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications
Closing Panel, • 9/22/25 Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Previous Case Studies in Rare Disease Commercialization: Lessons Learned You Might Also Like Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories What Matters to Payers: Conversations You Should Start During Phase 2 AI-Driven Patient Identification and Recruitment How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications
